BioCentury
ARTICLE | Company News

Novimmune, Tiziana deal

January 6, 2017 9:34 PM UTC

Novimmune granted Tiziana exclusive, worldwide rights to develop and commercialize NI-1201. Tiziana said it considers the compound a candidate to treat autoimmune inflammatory disease and will initial...